SCHEMBL23955925

SCHEMBL23955925

CCC[C@H](N)C(=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 3/20 0.43
SLC1A1 P43005 3/20 0.43
SLC1A3 P43003 2/20 0.43
GRIK1 P39086 2/20 0.43
GRIK2 Q13002 2/20 0.43
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41
GABRE P78334 2/20 0.41
GABRA6 Q16445 2/20 0.41
GABRG1 Q8N1C3 2/20 0.41
GABRG3 Q99928 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15604265 1.00 SLC1A2 (0.43) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL12462681 1.00 SLC1A2 (0.43) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL13300681 0.86 SLC15A1 (0.55) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL13857618 0.86 SLC15A1 (0.55) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL13484492 0.86 SLC15A1 (0.55) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL13300673 0.84 OPRM1 (0.56) SLC1A2SLC1A1GRIK1GRIK2TP53
SCHEMBL17173878 0.84 OPRM1 (0.56) SLC1A2SLC1A1GRIK1GRIK2TP53
SCHEMBL14133799 0.84 OPRM1 (0.56) SLC1A2SLC1A1GRIK1GRIK2TP53
SCHEMBL23845046 0.83 SLC1A3 (0.42) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL20383849 0.82 OPRM1 (0.54) SLC1A2SLC1A1GRIK1GRIK2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3900742-A1 TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES Seagen Inc. (US) 2021-10-27 EP disclosed